New research commissioned by Challenge Works and conducted by the [...]

Nucleome Therapeutics and Oxford University scientists have mapped the 3D [...]

Enhanced Genomics has secured an additional funding round, bringing its [...]

Causaly has introduced a new artificial intelligence system that it [...]

Biostate AI has launched K-Dense Beta, a multi-agent AI system [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

New natural language capability aims to reduce barriers for researchers [...]

Appointment strengthens expertise in targeted protein degradation as company advances [...]

Sygnature Discovery has completed a major upgrade of its high-throughput [...]

A new AI-led collaboration is being launched to advance drug [...]